Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

黄藤素注射液 - NMPA Drug Approval Details

Approvals/NMPA/INJECTIO FIBRAURETINI

Approved

中药

INJECTIO FIBRAURETINI

昆药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 12, 2020
Approval ID: 7LeaeXTfNiX
Company: 昆药集团股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeXTfNiX
Approval Number: 国药准字Z53020721
Generic Name: 黄藤素注射液
Generic Name En: INJECTIO FIBRAURETINI
Drug Type: 中药
Dosage Form: 注射剂
Strength: 2ml:20mg
Reg Date: 2020-08-12
Company Name: 昆药集团股份有限公司
Production Company Name: 昆药集团股份有限公司
Production Company Address: 云南省昆明市西郊七公里
Company Detail Path: /organization/kpc-pharmaceuticals-inc
Production Company Detail Path: /organization/kpc-pharmaceuticals-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 12, 2020

Approval ID

7LeaeXTfNiX

Type

中药

Back to NMPA Approvals